THROMBOSIS RESEARCH INSTITUTE

Mark For: THROMBOSIS RESEARCH INSTITUTE® trademark registration is intended to cover the categories of publications and documents, namely, pamphlets, booklets, printed lectures, scientific reports and newsletters, in the fields of biology, vascular biology, coagulation, anticoagulants, fibrinolysis, cytology, cell culture, proteins, protein biochemistry and/or proteolysis, vascular disorders, thrombotic disorders, artherosclerosis, haemostasis, hypercoagulability, pharmaceuticals, candidate pharmaceutical products, medicine, molecular biology, chemistry and disease. [all]

Status

2022-05-23 UTC
⟳ Refresh

DEAD REGISTRATION Cancelled Invalidated

Research	OneLook Acronym Finder
Serial Number	76586055
Registration Number	2988319
Mark Literal Elements	THROMBOSIS RESEARCH INSTITUTE
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	TRADEMARK. SERVICE MARK
Register	April 25, 2005
Current Location	PUBLICATION AND ISSUE SECTION 2005-08-23
Basis	44(e)
Class Status	SECTION 8 - CANCEL
Primary US Classes	002: Receptacles 005: Adhesives 022: Games, Toys and Sporting Good 023: Cutlery, Machinery, Tools and Parts Thereof 029: Brooms, Brushes and Dusters 037: Paper and Stationery 038: Prints and Publications 050: Merchandise Not Otherwise Classified
Primary International Class	016 - Primary Class (Paper goods and printed matter) Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); playing cards; printers' type; printing blocks.
Filed Use	No
Current Use	No
Intent To Use	No
Filed ITU	Yes
44D Filed	Yes
44E Current	Yes
66A Current	No
Current Basis	No
No Basis	No
Cancellation Code	2
Domestic Representative	Debra S. Serota
Attorney Name	Debra S. Serota
Attorney Docket Number	17422-003001
Law Office Assigned	M30
Employee Name	HAYES, GINA CLARK

Timeline

(CANCELLED)
IC 016. US 002 005 022 023 029 037 038 050. G & S: PUBLICATIONS AND DOCUMENTS, NAMELY, PAMPHLETS, BOOKLETS, PRINTED LECTURES, SCIENTIF
IC REPORTS AND NEWSLETTERS, IN THE FIELDS OF BIOLOGY, VASCULAR BIOLOGY, COAGULATION, ANTICOAGULANTS, FIBRINOLYSIS, CYTOLOGY, CELL CULTURE, PROTEINS, PROTEIN BIOCHEMISTRY AND/OR PROTEOLYSIS, VASCULAR DISORDERS, THROMBOT
IC DISORDERS, ARTHEROSCLEROSIS, HAEMOSTASIS, HYPERCOAGULABILITY, PHARMACEUTICALS, CANDIDATE PHARMACEUTICAL PRODUCTS, MEDICINE, MOLECULAR BIOLOGY, CHEMISTRY AND DISEASE(CANCELLED)
IC 041. US 100 101 107. G & S: EDUCATIONAL SERVICES, NAMELY PROVIDING AND CONDUCTING PROGRAMS, TRAINING, TEACHING, LECTURING, AND ARRANGING AND/OR CONDUCTING OF COLLOQUIUMS, SEMINARS, SYMPOSIUMS AND/OR WORKSHOPS, ALL IN THE FIELDS OF BIOLOGY, MEDICINE, PHARMACEUTICALS, THROMBOSIS AND ATHEROSCLEROSIS AND/OR THE BIOLOGY OR TREATMENT THEREOF; PROVISION OF INFORMATION RELATING TO BIOLOGY, MEDICINE, PHARMACEUTICALS, THROMBOSIS AND ATHEROSCLEROSIS AND/OR THE BIOLOGY OR TREATMENT THEREOF(CANCELLED)
IC 042. US 100 101. G & S: MEDICAL RESEARCH; SCIENTIF
IC RESEARCH; MEDICAL AND SCIENTIF
IC RESEARCH IN THE FIELD OF BIOLOGY, MEDICINE, PHARMACEUTICALS, VASCULAR BIOLOGY, COAGULATION, ANTICOAGULANTS, FIBRINOLYSIS, CYTOLOGY, CELL CULTURE, PROTEINS, PROTEIN BIOCHEMISTRY, PROTEOLYSIS, THROMBOSIS, ATHEROSCLEROSIS, AND/OR THE BIOLOGY OR TREATMENT THEREOF; RESEARCH AND DEVELOPMENT SERVICES TO FIND AND DEVELOP NEW PHARMACEUTICAL PRODUCTS FOR OTHERS TO PUT ON THE MARKET; THE PROVISION OF REPORTS AND INFORMATION RELATING TO CHEMICALS, BIOLOGICAL PRODUCTS, THE PREPARATION OF EITHER, FORMULATIONS, CANDIDATE PHARMACEUTICAL PRODUCTS, PHARMACEUTICAL RESEARCH PROJECTS, PHARMACEUTICAL RESEARCH SERVICES, MEDICINE, CHEMISTRY, MOLECULAR BIOLOGY, AND DISEASE; ARRANGING INVESTIGATIONS AND RESEARCH IN THE FIELD OF PHARMACEUTICALS TO OBTAIN INFORMATION AND DATA, TO BE SUPPLIED TO OTHERS, RELATING TO DRUGS, FORMULATIONS AND CANDIDATE PHARMACEUTICAL PRODUCTS; PHARMACEUTICAL DRUG DEVELOPMENT SERVICES; ARRANGING AND CONDUCTING MEDICAL AND SCIENTIF
IC RESEARCH; PREPARING OR ARRANGING THE PREPARATION OF CHEMICALS, BIOLOGICAL PRODUCTS, FORMULATIONS AND/OR CANDIDATE PHARMACEUTICAL PRODUCTS FOR RESEARCH AND TESTING BY OTHERS; PROVIDING INFORMATION IN THE FIELD OF BIOLOGY, MEDICINE, PHARMACEUTICALS, VASCULAR BIOLOGY, COAGULATION, ANTICOAGULANTS, FIBRINOLYSIS, CYTOLOGY, CELL CULTURE, PROTEINS, PROTEIN BIOCHEMISTRY, PROTEOLYSIS, THROMBOSIS, ATHEROSCLEROSIS, AND/OR THE BIOLOGY OR TREATMENT THEREOF, PHARMACEUTICAL DRUG DEVELOPMENT, CLINICAL TRIALS, MEDICAL AND SCIENTIF
IC RESEARCH, THE PREPARATION OF CHEMICALS, BIOLOGICAL PRODUCTS, FORMULATIONS AND/OR CANDIDATE PHARMACEUTICAL PRODUCTS FOR RESEARCH AND TESTING; PROMOTING PUBL
IC AWARENESS FOR THE NEED FOR THROMBOSIS AND ATHEROSCLEROSIS TESTING AND TREATMENT, AND RESEARCH ON THE TESTING AND TREATMENT FOR THROMBOSIS AND ATHEROSCLEROSIS; PROVIDING REPORTS AND INFORMATION RELATING TO INTELLECTUAL PROPERTY RIGHTS(CANCELLED)
IC 044. US 100 101. G & S: MEDICAL SERVICES; MEDICAL TESTING